Literature DB >> 23001565

A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult.

Katherine E Hekman1, Guo-Yun Yu, Christopher D Brown, Haipeng Zhu, Xiaofei Du, Kristina Gervin, Dag Erik Undlien, April Peterson, Giovanni Stevanin, H Brent Clark, Stefan M Pulst, Thomas D Bird, Kevin P White, Christopher M Gomez.   

Abstract

The autosomal dominant spinocerebellar ataxias (SCAs) are a genetically heterogeneous group of disorders exhibiting cerebellar atrophy and Purkinje cell degeneration whose subtypes arise from 31 distinct genetic loci. Our group previously published the locus for SCA26 on chromosome 19p13.3. In this study, we performed targeted deep sequencing of the critical interval in order to identify candidate causative variants in individuals from the SCA26 family. We identified a single variant that co-segregates with the disease phenotype that produces a single amino acid substitution in eukaryotic elongation factor 2. This substitution, P596H, sits in a domain critical for maintaining reading frame during translation. The yeast equivalent, P580H EF2, demonstrated impaired translocation, detected as an increased rate of -1 programmed ribosomal frameshift read-through in a dual-luciferase assay for observing translational recoding. This substitution also results in a greater susceptibility to proteostatic disruption, as evidenced by a more robust activation of a reporter gene driven by unfolded protein response activation upon challenge with dithiothreitol or heat shock in our yeast model system. Our results present a compelling candidate mutation and mechanism for the pathogenesis of SCA26 and further support the role of proteostatic disruption in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001565      PMCID: PMC3516132          DOI: 10.1093/hmg/dds392

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  92 in total

Review 1.  Genetics of the dominant ataxias.

Authors:  Dineke S Verbeek; Bart P C van de Warrenburg
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

2.  Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.

Authors:  Michael F Waters; Natali A Minassian; Giovanni Stevanin; Karla P Figueroa; John P A Bannister; Dagmar Nolte; Allan F Mock; Virgilio Gerald H Evidente; Dominic B Fee; Ulrich Müller; Alexandra Dürr; Alexis Brice; Diane M Papazian; Stefan M Pulst
Journal:  Nat Genet       Date:  2006-02-26       Impact factor: 38.330

3.  Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4.

Authors:  Keiko Hiramoto; Hideshi Kawakami; Kimiko Inoue; Takahiro Seki; Hirofumi Maruyama; Hiroyuki Morino; Masayasu Matsumoto; Kaoru Kurisu; Norio Sakai
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

Review 4.  TATA-binding protein in neurodegenerative disease.

Authors:  W M C van Roon-Mom; S J Reid; R L M Faull; R G Snell
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging.

Authors:  Anat Ben-Zvi; Elizabeth A Miller; Richard I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

Review 6.  Molecular pathogenesis of spinocerebellar ataxia type 1 disease.

Authors:  Seongman Kang; Sunghoi Hong
Journal:  Mol Cells       Date:  2009-06-22       Impact factor: 5.034

7.  Saccharomyces cerevisiae elongation factor 2. Mutagenesis of the histidine precursor of diphthamide yields a functional protein that is resistant to diphtheria toxin.

Authors:  L D Phan; J P Perentesis; J W Bodley
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

8.  Codon 101 of PRKCG, a preferential mutation site in SCA14.

Authors:  Dagmar Nolte; Stephan Klebe; Ralf Baron; Günther Deuschl; Ulrich Müller
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

9.  Benign SCA14 phenotype in a German patient associated with a missense mutation in exon 3 of the PRKCG gene.

Authors:  Stefan Wieczorek; Larissa Arning; Elke R Gizewski; Ingrid Alheite; Duymal Timmann
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

10.  Progressive disruption of cellular protein folding in models of polyglutamine diseases.

Authors:  Tali Gidalevitz; Anat Ben-Zvi; Kim H Ho; Heather R Brignull; Richard I Morimoto
Journal:  Science       Date:  2006-02-09       Impact factor: 63.714

View more
  26 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 2.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

3.  Adipose tissue proteomic analyses to study puberty in Brahman heifers.

Authors:  L T Nguyen; L F Zacchi; B L Schulz; S S Moore; M R S Fortes
Journal:  J Anim Sci       Date:  2018-06-04       Impact factor: 3.159

Review 4.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability.

Authors:  Katherine E Hekman; Christopher M Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-18       Impact factor: 10.154

Review 6.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

7.  Identification and characterization of novel PDYN mutations in dominant cerebellar ataxia cases.

Authors:  Justyna Jezierska; Giovanni Stevanin; Hiroyuki Watanabe; Michiel R Fokkens; Fabien Zagnoli; Jérôme Kok; Jean-Yves Goas; Pierre Bertrand; Christophe Robin; Alexis Brice; Georgy Bakalkin; Alexandra Durr; Dineke S Verbeek
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

Review 8.  Translation Elongation and Recoding in Eukaryotes.

Authors:  Thomas E Dever; Jonathan D Dinman; Rachel Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-08-01       Impact factor: 10.005

Review 9.  mRNA Translation Gone Awry: Translation Fidelity and Neurological Disease.

Authors:  Mridu Kapur; Susan L Ackerman
Journal:  Trends Genet       Date:  2018-01-16       Impact factor: 11.639

Review 10.  Regulation of mRNA Translation in Neurons-A Matter of Life and Death.

Authors:  Mridu Kapur; Caitlin E Monaghan; Susan L Ackerman
Journal:  Neuron       Date:  2017-11-01       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.